CALCULLI, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 7.464
EU - Europa 6.360
AS - Asia 6.183
AF - Africa 422
SA - Sud America 349
Continente sconosciuto - Info sul continente non disponibili 316
OC - Oceania 13
Totale 21.107
Nazione #
US - Stati Uniti d'America 7.371
VN - Vietnam 1.691
SG - Singapore 1.688
GB - Regno Unito 1.646
CN - Cina 1.596
IT - Italia 1.189
DE - Germania 773
SE - Svezia 744
UA - Ucraina 456
FR - Francia 400
HK - Hong Kong 383
IN - India 321
RU - Federazione Russa 315
BR - Brasile 239
IE - Irlanda 231
CH - Svizzera 146
EE - Estonia 124
ZA - Sudafrica 123
TG - Togo 118
JP - Giappone 116
NL - Olanda 98
FI - Finlandia 93
BD - Bangladesh 89
SC - Seychelles 53
CA - Canada 52
NG - Nigeria 52
AR - Argentina 51
CI - Costa d'Avorio 49
KR - Corea 35
JO - Giordania 34
PH - Filippine 34
TR - Turchia 28
IQ - Iraq 26
AT - Austria 24
BE - Belgio 23
TH - Thailandia 23
BG - Bulgaria 20
PL - Polonia 20
CL - Cile 16
ID - Indonesia 15
MX - Messico 15
EC - Ecuador 14
LB - Libano 14
TW - Taiwan 14
AU - Australia 11
GR - Grecia 11
SA - Arabia Saudita 11
IR - Iran 10
CO - Colombia 9
ES - Italia 9
PK - Pakistan 9
PY - Paraguay 9
AE - Emirati Arabi Uniti 8
JM - Giamaica 7
UZ - Uzbekistan 7
EG - Egitto 6
MY - Malesia 6
CZ - Repubblica Ceca 5
NP - Nepal 5
HN - Honduras 4
KE - Kenya 4
KZ - Kazakistan 4
MA - Marocco 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
UY - Uruguay 4
AL - Albania 3
BY - Bielorussia 3
OM - Oman 3
PE - Perù 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BO - Bolivia 2
CM - Camerun 2
CR - Costa Rica 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
LU - Lussemburgo 2
LV - Lettonia 2
MM - Myanmar 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
EU - Europa 1
GA - Gabon 1
IS - Islanda 1
KH - Cambogia 1
Totale 20.782
Città #
Southend 1.496
Singapore 1.118
Ashburn 677
Chandler 612
Dong Ket 479
Fairfield 447
Santa Clara 405
San Jose 385
Hong Kong 362
Jacksonville 316
Princeton 297
Ho Chi Minh City 276
Hanoi 271
Wilmington 268
Council Bluffs 234
Beijing 230
Dublin 230
Woodbridge 194
Seattle 185
Houston 181
Ann Arbor 178
Boardman 169
Cambridge 150
Los Angeles 146
New York 146
Lauterbourg 140
Westminster 138
Padova 137
Nanjing 135
Bern 132
Lomé 118
Tokyo 107
Berlin 97
Helsinki 90
Hefei 89
Medford 83
Milan 77
Jinan 74
Dallas 69
Shenyang 67
Bologna 61
Saint Petersburg 60
Buffalo 59
Turin 58
Mülheim 52
Tianjin 51
Abeokuta 49
Abidjan 49
Rome 47
Hebei 44
Haiphong 43
Redondo Beach 42
Florence 41
Nanchang 41
Bremen 39
Da Nang 37
Mahé 36
Changsha 35
Amman 34
Des Moines 34
Frankfurt am Main 34
San Diego 34
Shanghai 34
Guangzhou 33
Jiaxing 33
Dearborn 30
Phoenix 29
Grafing 28
Munich 28
Zhengzhou 28
São Paulo 27
Yubileyny 26
Olalla 24
Norwalk 23
Falkenstein 22
Brussels 21
Verona 21
Atlanta 20
Redwood City 19
Seoul 19
Sofia 19
The Dalles 19
Kunming 18
Ningbo 18
Brooklyn 17
Can Tho 17
Chengdu 17
Falls Church 17
Orem 17
Xi'an 17
Hangzhou 16
Redmond 16
Taiyuan 16
San Francisco 15
Toronto 15
Wuhan 15
Hải Dương 14
Amsterdam 13
Chicago 13
London 13
Totale 12.772
Nome #
Neoplasia papillare intraduttale mucinosa (IMPN) multifocale del pancreas. Caso clinico 730
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: a single center prospective, randomized controlled study. 262
Air in the Wirsung duct. An unusual finding. 240
A study of the relationship between idiopathic hyperenzymemia and dyslipidemia. 240
Are the New IPMN’s Guideline Effective to Predict the Presence of Invasive IPM Carcinoma? A Single Center Experience. 239
Comparing recist and Choi’s criteria to evaluate radiological response to chemotherapy in patients with advanced pancreatic cancer 233
Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases 224
Adenocarcinoma del colon e neoplasia intraduttale mucinosa (IPMN) multifocale sincrona del pancreas in un paziente anziano: possibili strategie terapeutiche. 222
Chronic asymptomatic pancreatic hyperenzymemia is a benign condition in only half of the cases: a prospective study 220
Intraductal papillary mucinous neoplasms: the bologna experience. Lessons learned from 357 cases observed in a tertiary care center 220
Intraductal Papillary Mucinous Neoplasms: The Bologna Experience 212
Can pancreatic steatosis explain the finding of pancreatic hyperenzymemia in subject with dyslipidemia? 208
A study of the relationship between idiopathic pancreatic hyperenzynemia and dyslipidemia 205
Are There Prognostic Factors Related to Recurrence in Pancreatic Endocrine tumors? 197
Co-morbidities and pancreatic stump treatment after pancreaticoduodenectomy: are they linked to postoperative morbidity? 195
Autoimmune Pancreatitis Associated with Anisakis Infection 194
Discovery of new potentially actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 194
Autoimmune pancreatitis associated with high levels of chromogranin a, serotonin and 5-hydroxyindoleacetic Acid 193
Branch duct intraductal papillary mucinous neoplasm: validation of Fukuoka 2012 guidelines using a systematic review and meta-analysis 193
Magnetic resonance cholangiopancreatography in asymptomatic pancreatic hyperenzymemia 192
Discovery of new potential actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 191
Adenocarcinoma del colon e neoplasia papillare intraduttale mucinosa multifocale sincrona del pancreas in un paziente anziano. Caso clinico. 190
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: An interim report of a prospective randomized study 188
GemOx and Ovarian Pancreatic Cancer Metastasis (PC) 187
Il percorso diagnostico preoperatorio e la preparazione all'intervento chirurgico 185
Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis. 183
Comparing RECIST and Choi's Criteria After Neoadjuvant Chemoradiotherapy in Patients with Resectable Pancreatic Cancer 179
Prospective validation of a preoperative risk score model based on pancreatic texture to predict postoperative pancreatic fistula after pancreaticoduodenectomy. 179
Practical guidelines for acute pancreatitis. 176
Neoadjuvant Chemoradiotherapy and Surgery Versus Surgery Alone in Resectable Pancreatic Cancer: A Single-Center Prospective, Randomized, Controlled Trial Which Failed to Achieve Accrual Targets 175
Intraductal papillary mucinous neoplasms: the Bologna experience. Lessons learned from 357 cases observed in a tertiary care center 175
Nuove metodiche di trattamento delle fistole pancreatiche: l'utilizzazione di sostanze sclerosanti 173
Risk Factors in Resected Pancreatic Cancer. A Single Centre Experience 173
I tumori cistici del pancreas: aspetti morfologici in TC e RM. 172
A prospective study on radiofrequency ablation locally advanced pancreatic cancer. 171
Comparison of Clinical Data and Scores of Quality of Life, Anxiety, and Depression in Patients with Different Types of Intraductal Papillary Mucinous Neoplasms: A Prospective Study 170
Cystic dystrophy of the duodenal wall is not always associated with chronic pancreatitis. 167
Sclerosing cholangitis, autoimmune chronic pancreatitis, and situs viscerum inversus totalis. 166
Peripancreatic vascular anatomic variations: impact of radiological diagnosis with multidetector computed tomography (MDTC) on surgical strategy 164
A bizarre abdominal cystic lesion 164
Comparative study between Balthazar computer tomography severità and Mortele modified computer tomography severità index for the assessment of acute pancreatitis. 163
Prevalence of Asymptomatic Intraductal Papillary Mucinous Neoplasms in Healthy and Ill Populations Detected by Ultrasonography: A Single-Center Study of 6353 Outpatients 161
Prognostic factors in periampullary and pancreatic tumor Resection in elderly patients. 160
Gemox in combination witherlotinib (E) in pancreatic cancer (PC). 160
Assessment of complications according to the Clavien-Dindo classification after distal pancreatectomy. 159
Preoperatory Gemcitabine and Oxaliplatin in a patient with ovarian metastasis from pancreatic cystadenocarcinoma 158
Risk Factors for Malignancy of Branch-Duct Intraductal Papillary Mucinous Neoplasms: A Critical Evaluation of the Fukuoka Guidelines With a Systematic Review and Meta-analysis 157
Characterization of neuroendocrine pancreatic cancer with multidetector computer tomography and magneti resonance. 153
Natural history of branch-duct intraductal papillary mucinous neoplasms of the pancreas: a case report. 153
Long-term survival in neuroendocrine tumors of the pancreas. 151
Fagan’s normogram: i sit useful in routine clinical setting ? 151
Adenocarcinoma of the pancreas and autoimmune pancreatitis: a challenge for the diagnostic imaging. 150
Neuroendocrine pancreatic cancer: diagnosis and characterization with spiral computer tomography and nuclear magnetic resonance. 149
A study of the relationship between idiopathic pancreatic hyperenzynemia and dyslipidemia. 149
Early pancreatic cancer and Peutz-Jeghers syndrome: a case report. 149
Total pancreatectomy: indications, operative technique, and results : A single centre experience and review of literature 147
Pancreatic involvement in Von Hippel-Lindau disease: the role of integrated imaging. 146
Pancreatic and extrapancreatic lesions in patients with intraductal papillary mucinous neoplasms of the pancreas: a single-centre experience 146
Synchronous adenocarcinoma of the sigmoid colon and multifocal intraductal papillary mucinous neoplasm of the pancreas in an elderly patient 146
Italian consensus guidelines for chronic pancreatitis 145
Resezione della coda del pancreas "spleen preserving" ecoguidata per neoplasia intraduttale mucinosa (IPMN) del pancreas. 145
The Clinical Impact of Splanchnic Ischemia on Patients Affected by Thoracoabdominal Aortic Aneurysms Treated with Fenestrated and Branched Endografts 145
Left pancreatectomies and the pancreatic remnant: stapler or handsewn closure ? 145
Usefulness of the Clavien-Dindo classification after pancreaticoduodenectomy 144
Follow-up Strategy for IPMN 144
Incidental Cystic Lesion of the Pancreas: What Kind of Management? 142
Useful of Choi’s criteria after neoadjuvant chemoradiotherapy in patients with resectable pancreatic cancer. 142
Neuroendocrine pancreatic cancer: diagnoses and characterization with spiral computed tomography and nuclear magnetic resonance. 141
Autoimmune pancreatitis: the classification puzzle. 141
Serum determination of Ca 19-9 in diagnosing pancreatic cancer: an obituary. 141
The surgical treatment of neuroendocrine pancreatoduodenal tumors in multiple endocrine neoplasia type 1 140
The role of intraoperative ultrasonography (IOUS) in pancreatic surgery for multifocal intra ductal papillary mucinous neoplasms (IPMNs) 140
The role of intraoperative ultrasonography (IOUS) in pancreatic surgery for multifocal intra ductal papillary mucinous neoplasms (IPMNs). 139
Report of three cases of chronic pancreatic fistulas treated with prolamine as a sclerosing substance following pancreatic resection. 138
New methods of treating the pancreatic fistulas: the use of sclerosing substances 138
Long-Term Survival After Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma. Case Report 137
Therapeutic management and clinical out come of autoimmune pancreatitis. 137
Value of both WHO and TNM classification systems for patients with pancreatic endocrine tumors: results of a single-center series. 137
Neoadjuvant Therapy for Resectable Pancreatic Adenocarcinoma: An Interim Report of a Prospective Controlled Randomized Study 137
Prognostic factors in resected pancreatic cancer:a single centre experience 136
Characterization of neuroendocrine pancreatic cancer with multidetector computed tomography and magnetic resonance. 135
Is total pancreatectomy as feasible, safe, efficacious, and cost-effective as pancreaticoduodenectomy? A single center, prospective, observational study 135
Intraductal Papillary Mucinous Neoplasms and Pancreatic Cancer 134
Autoimmune pancreatitis: a case mimicking carcinoma. 133
New methods of treating the pancreatic fistulas: the use of sclerosino substances. 131
Late Postpancreatectomy Hemorrhage After Pancreaticoduodenectomy: Is It Possible to Recognize Risk Factors? 131
Radiofrequency ablation of unresectable pancreatic carcinoma: preliminary results. 130
Varianti anatomiche delle strutture vascolari peripancreatiche: importanza dello studio radiologico mediante TC multidetettore sulla pianificazione chirurgica. 130
The usefulness of a grading system for complications resulting from pancreatic resections: a single center experience. 130
Organizing pneumonia after pancreatic cancer treatment with nab-paclitaxel and gemcitabine: a case report 129
Comparing RECIST and Choi’s Criteria to Evaluate Radiological Response to Chemotherapy in Patients with Advanced Pancreatic Cancer 128
Serous Cystic Tumors of the Pancreas: When to Observe and When to Operate 128
Sclerosing Cholangitis, Autoimmune Chronic Pancreatitis and Situs Viscerum Inversus Totalis: An Incidental Association? 127
Peripancreatic vascular anatomic variations: impact of radiological diagnosis with multidetector computer tomography (MDCT) on surgical strategy. 126
Exocrine pancreatic function assessed by secretin cholangio-Wirsung magnetic resonance imaging. 125
What is the Outcome of Patients Affected by Intraductal Papillary Mucinous Neoplasms Without High-Risk Stigmata?: A Single-Center Retrospective Study 125
State of art in diagnosis and stadiation of pancreatic cancer with multidetector computer tomography. 124
Multifocal intraductal papillary mucinous neoplasms (IPMN) of the pancreas from mild dysplasia to invasive carcinoma: a case report 124
Pancreatic cystic tumor: radiological diagnosis with multidetector computed tomography and MR 123
Pancreatic cystic tumor: radiological diagnosis with multidetector computed tomography and MR. 123
Totale 16.774
Categoria #
all - tutte 56.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.362 0 122 119 232 230 147 34 140 70 180 644 444
2022/20233.024 281 472 172 351 204 222 72 162 451 153 269 215
2023/2024733 59 121 55 72 56 172 51 48 15 45 17 22
2024/20252.496 99 423 242 154 586 113 161 55 19 135 39 470
2025/20265.543 375 488 525 355 725 383 508 169 1.109 460 216 230
2026/2027354 122 232 0 0 0 0 0 0 0 0 0 0
Totale 21.107